Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.4600 (-0.88%) ($11.5000 - $13.5500) on Sat. Sep. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.77% (three month average) | RSI | 43 | Latest Price | $13.4600(-0.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -3.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ATRA price | ATRA will decline at least -1.885% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.885% (StdDev 3.77%) | Hourly BBV | 0 () | Intraday Trend | 13.6% | | | |
|
Resistance Level | $14.62 | 5 Day Moving Average | $14.21(-5.28%) | 10 Day Moving Average | $14.76(-8.81%) | 20 Day Moving Average | $14.62(-7.93%) | To recent high | -33.1% | To recent low | 11.9% | Market Cap | $N/A | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |